speb/financial-data huggingface dataset:
Financial ratios for OBE.TO — annual report dated 2023-12-31
Total revenue: 569015151.5151515
Gross profit: 324469696.96969694
Operating income: 110075757.57575758
Net income: 81818181.81818181
Capital expenditures: 454545.45454545453
Operating cash flow: 267196969.6969697
Depreciation & amortization: 159848484.84848484
Net tangible assets: 1245303030.3030303
Owner earnings: 241212121.2121212
Return on net tangible assets (%): 19.369753011315243
Capex to operating income (%): 0.4129387474191328
Buffett classification: The Great
Stock price: 6.8106060606060606
P/E ratio: 5.558547632592592
Shares outstanding: 66776768
Book value: 1245303030.3030303
P/B ratio: 0.3652044922253316
Market cap (USD): 454790260.8484849
Debt to equity: 0.13870300523178003
Current ratio: 0.41130434782608694
Quick ratio: 0.41130434782608694
Effective tax rate (%): 24.79108635097493
Interest coverage ratio: 5.0103448275862075
COGS to revenue (%): 42.976967114898144
SG&A to revenue (%): 4.6864598588736515
Free cash flow (dilution-adjusted): 39090909.090909086
Buyback yield (%): 7.895747556708159
Retained earnings: -481363636.3636363
Receivables turnover: 10.73
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.191645218768561
FCF margin (%): 6.869924111303422
Revenue growth (%): -15.88471673254282
Rule of 40 score: -9.014792621239398
Financial ratios for OBE.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.562962962962962
Shares outstanding: 66776768
Market cap (USD): 371476687.17037034
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OBE.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 279720.27972027974
Buffett classification: The Gruesome
Stock price: 5.846153846153846
Shares outstanding: 66776768
Market cap (USD): 390387259.0769231
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OBE.TO — annual report dated 2024-12-31
Total revenue: 585804195.8041959
Gross profit: 43566433.56643357
Operating income: -174475524.4755245
Net income: -141678321.6783217
Capital expenditures: 58321678.321678326
Operating cash flow: 253076923.0769231
Depreciation & amortization: 172797202.7972028
Net tangible assets: 983076923.0769231
Owner earnings: -27202797.20279722
Return on net tangible assets (%): -2.767107696685163
Buffett classification: The Gruesome
Stock price: 5.846153846153846
Shares outstanding: 66776768
Book value: 983076923.0769231
P/B ratio: 0.3971075405320813
Market cap (USD): 390387259.0769231
Debt to equity: 0.24363351828140561
Current ratio: 1.7875045405012715
Quick ratio: 1.7875045405012715
Interest coverage ratio: -7.4924924924924925
COGS to revenue (%): 92.56297003700608
SG&A to revenue (%): 3.4260475110421384
Free cash flow (dilution-adjusted): -50909090.909090914
Buyback yield (%): 7.469721022604691
Retained earnings: -586013986.013986
Receivables turnover: 9.519318181818182
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.564943184907301
FCF margin (%): -8.690461979228841
Revenue growth (%): 2.950544329854691
Rule of 40 score: -5.73991764937415
Financial ratios for OBE.TO — quarterly report dated 2025-03-31
Total revenue: 150909090.9090909
Gross profit: 91188811.1888112
Operating income: 29020979.02097902
Net income: 10769230.76923077
Capital expenditures: 0
Operating cash flow: 67622377.62237762
Depreciation & amortization: 38671328.67132867
Net tangible assets: 987272727.2727274
Owner earnings: 49440559.44055944
Return on net tangible assets (%): 5.007791471879869
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.895104895104895
P/E ratio: 9.138444062337662
Shares outstanding: 66776768
Book value: 987272727.2727273
P/B ratio: 0.3987308076498088
Market cap (USD): 393656051.91608393
Debt to equity: 0.25286867828304294
Current ratio: 1.5637348629700445
Quick ratio: 1.5637348629700445
Effective tax rate (%): 24.509803921568626
Interest coverage ratio: 5.3896103896103895
COGS to revenue (%): 39.57367933271548
SG&A to revenue (%): 3.9388322520852648
Free cash flow (dilution-adjusted): -23636363.636363637
Buyback yield (%): 1.7053686030255144
Retained earnings: -575244755.2447553
Receivables turnover: 2.509302325581395
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2315427219443995
FCF margin (%): -15.66265060240964
Rule of 40 score: -15.66265060240964
Financial ratios for OBE.TO — quarterly report dated 2025-06-30
Total revenue: 102335766.42335765
Gross profit: 55839416.05839416
Operating income: 12773722.627737226
Net income: 11167883.21167883
Capital expenditures: 153941605.83941606
Operating cash flow: 40291970.80291971
Depreciation & amortization: 34087591.24087591
Net tangible assets: 1016350364.9635036
Owner earnings: -108686131.38686132
Return on net tangible assets (%): -10.693766159149671
Capex to operating income (%): 1205.142857142857
Buffett classification: The Gruesome
Stock price: 5.532846715328467
P/E ratio: 16.84203408937804
Shares outstanding: 66776768
Book value: 1016350364.9635036
P/B ratio: 0.3635219056592933
Market cap (USD): 369465621.48905104
Debt to equity: 0.1632433208848032
Current ratio: 0.7979846449136275
Quick ratio: 0.7979846449136275
Effective tax rate (%): 21.938775510204085
Interest coverage ratio: 3.30188679245283
COGS to revenue (%): 45.43509272467903
SG&A to revenue (%): 3.4236804564907275
Free cash flow (dilution-adjusted): 9197080.291970802
Buyback yield (%): 7.230802248794609
Retained earnings: -589270072.9927007
Receivables turnover: 2.058737151248164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0582970488630865
FCF margin (%): 8.98716119828816
Revenue growth (%): -32.18714273150999
Rule of 40 score: -23.199981533221827
Financial ratios for OBE.TO — quarterly report dated 2025-09-30
Total revenue: 94100719.42446044
Gross profit: 49928057.55395684
Operating income: 1654676.2589928058
Net income: 12086330.935251798
Capital expenditures: 215827.3381294964
Operating cash flow: 32661870.503597125
Depreciation & amortization: 32086330.935251802
Net tangible assets: 1009352517.9856116
Owner earnings: 43956834.53237411
Return on net tangible assets (%): 4.354953670705631
Capex to operating income (%): 13.043478260869565
Buffett classification: The Great
Stock price: 6.525179856115108
P/E ratio: 12.806769640281095
Shares outstanding: 66776768
Book value: 1009352517.9856117
P/B ratio: 0.4316930048182466
Market cap (USD): 435730421.41007197
Debt to equity: 0.10662865288667141
Current ratio: 0.5247933884297521
Quick ratio: 0.5247933884297521
Effective tax rate (%): 2.3255813953488373
Interest coverage ratio: 0.48936170212765956
COGS to revenue (%): 46.94189602446483
SG&A to revenue (%): 9.250764525993885
Free cash flow (dilution-adjusted): -15755395.68345324
Buyback yield (%): 1.4364369569378703
Retained earnings: -568705035.9712231
Receivables turnover: 2.147783251231527
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.1407674888304058
FCF margin (%): -16.743119266055047
Revenue growth (%): -8.047085869107832
Rule of 40 score: -24.79020513516288
Financial ratios for OBE.TO — annual report dated 2025-12-31
Total revenue: 448175182.4817518
Gross profit: 243941605.83941603
Operating income: 38540145.98540146
Net income: 25693430.656934306
Capital expenditures: 151824817.51824817
Operating cash flow: 175036496.35036495
Depreciation & amortization: 148321167.88321167
Net tangible assets: 1015766423.3576641
Owner earnings: 22189781.021897823
Return on net tangible assets (%): 2.1845357861454455
Capex to operating income (%): 393.93939393939394
Buffett classification: The Gruesome
Stock price: 6.145985401459853
P/E ratio: 15.973306436363634
Shares outstanding: 66776768
Book value: 1015766423.3576641
P/B ratio: 0.40403879459614833
Market cap (USD): 410409041.2846715
Debt to equity: 0.14357574015521704
Current ratio: 0.5375894988066826
Quick ratio: 0.5375894988066826
Effective tax rate (%): 25.106382978723403
Interest coverage ratio: 2.3056768558951966
COGS to revenue (%): 45.5700325732899
SG&A to revenue (%): 5.26058631921824
Free cash flow (dilution-adjusted): -49416058.39416058
Buyback yield (%): 9.764159331210772
Retained earnings: -585985401.459854
Receivables turnover: 10.944741532976828
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.129445234708393
FCF margin (%): -11.026058631921824
Revenue growth (%): -23.49402996909335
Rule of 40 score: -34.520088601015175
Financial ratios for OBE.TO — quarterly report dated 2025-12-31
Total revenue: 92846715.32846715
Gross profit: 42262773.72262774
Operating income: -6204379.562043795
Net income: -8978102.189781021
Capital expenditures: 1897810.218978102
Operating cash flow: 31021897.810218975
Depreciation & amortization: 41313868.61313868
Net tangible assets: 1015766423.3576641
Owner earnings: 30437956.20437956
Buffett classification: The Gruesome
Stock price: 6.145985401459853
P/E ratio: 16.386641052126055
Shares outstanding: 66776768
Book value: 1015766423.3576641
P/B ratio: 0.40403879459614833
Market cap (USD): 410409041.2846715
Debt to equity: 0.14357574015521704
Current ratio: 0.5375894988066826
Quick ratio: 0.5375894988066826
Interest coverage ratio: -1.6346153846153846
COGS to revenue (%): 54.48113207547169
SG&A to revenue (%): 5.4245283018867925
Free cash flow (dilution-adjusted): -17956204.379562043
Buyback yield (%): 0
Retained earnings: -585985401.459854
Receivables turnover: 2.267379679144385
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5037932669511618
FCF margin (%): -19.339622641509436
Revenue growth (%): -1.332619031674832
Rule of 40 score: -20.672241673184267
Financial ratios for OBM.AX — annual report dated 2021-06-30
Total revenue: 18883458.64661654
Gross profit: 3442857.1428571427
Operating income: -16386466.165413532
Net income: -16754887.218045112
Capital expenditures: 35650375.93984962
Depreciation & amortization: 5357142.857142857
Net tangible assets: 76704511.27819549
Owner earnings: -47048120.30075188
Return on net tangible assets (%): -61.336836017526494
Buffett classification: The Gruesome
Stock price: 0.10526315789473685
Shares outstanding: 1927653086
Book value: 76704511.27819549
P/B ratio: 2.6453574604232633
Market cap (USD): 202910851.15789476
Debt to equity: 0.26650460217414745
Current ratio: 1.4894767144319345
Quick ratio: 0.8397837768679632
Interest coverage ratio: -294.5135135135135
COGS to revenue (%): 81.76786780808281
SG&A to revenue (%): 44.71829583913996
Free cash flow (dilution-adjusted): -47290225.56390977
Buyback yield (%): 1.4569900823801176
Retained earnings: -259060150.37593985
Inventory turnover: 1.011027963765262
Receivables turnover: 17.990687679083095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.430035966129536
FCF margin (%): -250.43201274138957
Rule of 40 score: -250.43201274138957
Financial ratios for OBM.AX — annual report dated 2022-06-30
Total revenue: 106386896.55172414
Gross profit: 29971034.482758623
Operating income: -14946896.551724138
Net income: -60645517.24137931
Capital expenditures: 26992413.79310345
Depreciation & amortization: 28768965.51724138
Net tangible assets: 24024137.931034483
Owner earnings: -58868965.51724138
Return on net tangible assets (%): -245.04090713362996
Buffett classification: The Gruesome
Stock price: 0.020689655172413793
Shares outstanding: 1927653086
Book value: 24024137.931034476
P/B ratio: 1.6601002606573854
Market cap (USD): 39882477.64137931
Debt to equity: 0.6987225491603275
Current ratio: 1.3304244805964112
Quick ratio: 0.8633513451035918
Interest coverage ratio: -172.0079365079365
COGS to revenue (%): 71.82826508320315
SG&A to revenue (%): 8.133617699872294
Free cash flow (dilution-adjusted): -9954482.75862069
Buyback yield (%): 2.2860268264404224
Retained earnings: -297388275.86206895
Inventory turnover: 6.854924523632764
Receivables turnover: 124.80663430420711
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.77084750888334
FCF margin (%): -9.356869202196279
Revenue growth (%): 463.3867107855588
Rule of 40 score: 454.02984158336255
Financial ratios for OBM.AX — annual report dated 2023-06-30
Total revenue: 89992052.98013245
Gross profit: -2966225.1655629138
Operating income: -30643046.357615896
Net income: -29221854.304635763
Capital expenditures: 11076821.19205298
Depreciation & amortization: 11779470.198675497
Net tangible assets: 20586092.715231787
Owner earnings: -28519205.298013248
Return on net tangible assets (%): -138.53627151359177
Buffett classification: The Gruesome
Stock price: 0.08609271523178808
Shares outstanding: 1927653086
Book value: 20586092.71523179
P/B ratio: 8.061602096831267
Market cap (USD): 165956888.19867548
Debt to equity: 1.0229692777867136
Current ratio: 1.1703429661687375
Quick ratio: 0.783214667969659
Interest coverage ratio: -23.559572301425664
COGS to revenue (%): 103.29609678558813
SG&A to revenue (%): 11.302690450959615
Free cash flow (dilution-adjusted): -26617880.794701986
Buyback yield (%): 0.4118200311101797
Retained earnings: -313929139.07284766
Inventory turnover: 8.436530833032817
Receivables turnover: 20.993048045728408
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -64.5873173182954
FCF margin (%): -29.578034852231248
Revenue growth (%): -15.410585422633039
Rule of 40 score: -44.98862027486429
Financial ratios for ORCHPHARMA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.7610444415139126
Shares outstanding: 50719105
Market cap (USD): 190756807.9388105
Buyback yield (%): 0
Retained earnings: -305199261.5060003
Capitalized R&D asset: 873836.2125807728
Rule of 40 score: 0
Financial ratios for ORCHPHARMA.NS — annual report dated 2023-03-31
Total revenue: 81108209.50060903
Gross profit: 32731108.4043849
Operating income: 3613763.702801462
Net income: 5641693.05724726
Capital expenditures: 3211644.336175396
Operating cash flow: 2233617.539585871
Depreciation & amortization: 6673179.049939099
Net tangible assets: 83832314.25091353
Owner earnings: 9103227.771010961
Return on net tangible assets (%): 10.858853000007409
Capex to operating income (%): 88.87256058512251
Buffett classification: The Gruesome
Stock price: 4.668087697929355
P/E ratio: 41.966343737248565
Shares outstanding: 50719105
Book value: 83879293.54445797
P/B ratio: 2.8226421575069454
Market cap (USD): 236761230.10048723
Debt to equity: 0.48115324352464034
Current ratio: 1.3471924756589082
Quick ratio: 0.7321263152686656
Effective tax rate (%): 0
Interest coverage ratio: 0.9206627008878008
COGS to revenue (%): 59.64513505363581
R&D to revenue (%): 0.9554160214230879
SG&A to revenue (%): 3.472421618673359
Free cash flow (dilution-adjusted): -8109025.578562729
Buyback yield (%): 0
Retained earnings: -276277771.01096225
Inventory turnover: 1.7363796133567664
Receivables turnover: 3.094412571365904
Capitalized R&D asset: 1360391.0906873397
ROCI (R&D-adjusted, %): 3.645992643600573
FCF margin (%): -9.997786449103947
Rule of 40 score: -9.997786449103947
Financial ratios for ORCHPHARMA.NS — annual report dated 2024-03-31
Total revenue: 98221165.60738698
Gross profit: 38455414.31826358
Operating income: 9409893.272574648
Net income: 11052464.324259503
Capital expenditures: 7772490.706319703
Operating cash flow: 15108766.039093416
Depreciation & amortization: 3985741.69564696
Net tangible assets: 138451564.93584362
Owner earnings: 7265715.31358676
Return on net tangible assets (%): 5.247839067007718
Capex to operating income (%): 82.59913774976393
Buffett classification: The Gruesome
Stock price: 12.534189059500958
P/E ratio: 57.5186521618809
Shares outstanding: 50719105
Book value: 140240568.41347882
P/B ratio: 4.533088094197853
Market cap (USD): 635722850.9986804
Debt to equity: 0.11559172172669221
Current ratio: 3.041647193587982
Quick ratio: 2.467126942932436
Effective tax rate (%): -3.392346745670247
Interest coverage ratio: 4.798012779357363
COGS to revenue (%): 60.84813891134332
R&D to revenue (%): 0.8660715255895646
SG&A to revenue (%): 3.941402545801237
Free cash flow (dilution-adjusted): 7336275.332773713
Buyback yield (%): 0
Retained earnings: -261005468.28156853
Inventory turnover: 3.3368032378038373
Receivables turnover: 4.188588324756543
Capitalized R&D asset: 1658228.4525124128
ROCI (R&D-adjusted, %): 6.011591429695964
Rosenberg metric: 7.38695580907939
FCF margin (%): 7.469138945162314
Revenue growth (%): 21.098919840721493
Rule of 40 score: 28.568058785883807
Financial ratios for ORCHPHARMA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 144009651.21834686
Buffett classification: The Gruesome
Stock price: 16.336598184424272
Shares outstanding: 50719105
Book value: 146230673.67415196
P/B ratio: 5.666236897088748
Market cap (USD): 828577638.658624
Debt to equity: 0.1347264171040525
Current ratio: 2.9646454854531092
Quick ratio: 1.8242067895096894
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORCHPHARMA.NS — annual report dated 2025-03-31
Total revenue: 107777168.57610475
Gross profit: 44155167.17325228
Operating income: 30020680.38344634
Net income: 11650315.641805002
Capital expenditures: 17548281.50572831
Operating cash flow: 2246329.2027121815
Depreciation & amortization: 4038555.061959317
Net tangible assets: 146162158.05471122
Owner earnings: -1859410.8019639924
Return on net tangible assets (%): -1.2721560947861623
Capex to operating income (%): 58.45397666404851
Buffett classification: The Good
Stock price: 9.057066168747813
P/E ratio: 39.42951454090369
Shares outstanding: 50719105
Book value: 148151204.1150339
P/B ratio: 3.1006584978410787
Market cap (USD): 459366290.00466806
Debt to equity: 0.13778198659907231
Current ratio: 2.827392341481726
Quick ratio: 2.1334182630083873
Effective tax rate (%): -0.2024804111974283
Interest coverage ratio: 17.6612884368058
COGS to revenue (%): 59.03105661745699
R&D to revenue (%): 0.9075241296507669
SG&A to revenue (%): 3.5074944743389893
Free cash flow (dilution-adjusted): -15301952.303016132
Buyback yield (%): 0
Retained earnings: -242876700.95861584
Inventory turnover: 2.7461316322354814
Receivables turnover: 3.8122561066128116
Capitalized R&D asset: 1803773.6011843395
ROCI (R&D-adjusted, %): 18.17916720531703
Rosenberg metric: 6.700345244054685
FCF margin (%): -14.197767955103549
Revenue growth (%): 9.729066957844253
Rule of 40 score: -4.468700997259296
Financial ratios for ORCHPHARMA.NS — quarterly report dated 2025-03-31
Total revenue: 27762298.33995791
Gross profit: 11627601.122281972
Operating income: 7990226.794482113
Net income: 2606336.2169745145
Capital expenditures: 0
Depreciation & amortization: 1037140.5190554126
Net tangible assets: 146162158.05471122
Owner earnings: 3643476.736029927
Return on net tangible assets (%): 2.492763369480427
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.057066168747813
P/E ratio: 44.06245508665698
Shares outstanding: 50719105
Book value: 148151204.1150339
P/B ratio: 3.1006584978410787
Market cap (USD): 459366290.00466806
Debt to equity: 0.13778198659907231
Current ratio: 2.827392341481726
Quick ratio: 2.1334182630083873
Effective tax rate (%): -0.20634646304355797
Interest coverage ratio: 17.45808429118774
COGS to revenue (%): 58.117296414373165
Buyback yield (%): 0
Retained earnings: -242876700.95861584
Inventory turnover: 0.6964257871336814
Receivables turnover: 0.9819982541606346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.873864500257461
Rule of 40 score: 0
Financial ratios for ORCHPHARMA.NS — quarterly report dated 2025-06-30
Total revenue: 20235057.33676574
Gross profit: 8666440.439971918
Operating income: 646044.9333021297
Net income: 1744746.0800374446
Capital expenditures: 0
Depreciation & amortization: 1012649.1926047275
Owner earnings: 2757395.272642172
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.358296278960918
P/E ratio: 60.743123518671275
Shares outstanding: 50719105
Market cap (USD): 423925306.59372807
Effective tax rate (%): 0
Interest coverage ratio: 1.694888718342287
COGS to revenue (%): 57.171159459847054
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -27.113176693870162
Rule of 40 score: -27.113176693870162
Financial ratios for ORCHPHARMA.NS — quarterly report dated 2025-09-30
Total revenue: 21817835.40022548
Gross profit: 6879109.357384441
Operating income: -1169898.5343855694
Net income: -645276.2119503946
Capital expenditures: 0
Depreciation & amortization: 1003540.0225479143
Net tangible assets: 141857779.03043967
Owner earnings: 358263.81059751974
Buffett classification: The Gruesome
Stock price: 7.914317925591883
P/E ratio: 108.31843670654673
Shares outstanding: 50719105
Book value: 143612547.9143179
P/B ratio: 2.7950699830976076
Market cap (USD): 401407121.8714769
Debt to equity: 0.22106996990917174
Current ratio: 3.3528183934602978
Quick ratio: 1.895837605572888
Interest coverage ratio: -2.7803231251507117
COGS to revenue (%): 68.47024816534572
Buyback yield (%): 0
Inventory turnover: 0.43271596774219884
Receivables turnover: 0.9572222164515783
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6863667210362769
Revenue growth (%): 7.821959864595677
Rule of 40 score: 7.821959864595677
Financial ratios for ORCHPHARMA.NS — quarterly report dated 2025-12-31
Total revenue: 23088671.048234377
Gross profit: 7142742.564331069
Operating income: 3449203.52010694
Net income: -1405090.78756823
Capital expenditures: 0
Depreciation & amortization: 1005837.1393561324
Owner earnings: -399253.6482120976
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.454383424306561
P/E ratio: 186.37628092221883
Shares outstanding: 50719105
Market cap (USD): 428798760.60766405
Interest coverage ratio: 9.743997230701451
COGS to revenue (%): 69.06386448397478
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.824755869208566
Rule of 40 score: 5.824755869208566
Financial ratios for PAG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 95.88
Shares outstanding: 65749255
Market cap (USD): 6304038569.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PAG — annual report dated 2022-12-31
Total revenue: 27814800000
Gross profit: 4838800000
Operating income: 1487800000
Net income: 1386200000
Capital expenditures: 250200000
Operating cash flow: 1459000000
Depreciation & amortization: 127300000
Net tangible assets: 1302400000
Owner earnings: 1263300000
Return on net tangible assets (%): 96.99785012285012
Capex to operating income (%): 16.81677644844737
Buffett classification: The Great
Stock price: 104.72
P/E ratio: 4.967004749386812
Shares outstanding: 65749255
Book value: 4174800000
P/B ratio: 1.6492435526492286
Market cap (USD): 6885261983.6
Debt to equity: 1.6657324901791704
Current ratio: 0.9896246631728586
Quick ratio: 0.24508285417241307
Effective tax rate (%): 25.441049913941484
Interest coverage ratio: 12.115635179153095
COGS to revenue (%): 82.60350604714037
SG&A to revenue (%): 11.589873017242619
Free cash flow (dilution-adjusted): 1149800000
Buyback yield (%): 12.625518129456584
Retained earnings: 4483300000
Inventory turnover: 6.5475478042803
Receivables turnover: 30.67696040586743
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.825134287081848
FCF margin (%): 4.133770510663388
Rule of 40 score: 4.133770510663388
Financial ratios for PAG — annual report dated 2023-12-31
Total revenue: 30916500000
Gross profit: 5147400000
Operating income: 1450000000
Net income: 1114200000
Capital expenditures: 355300000
Operating cash flow: 1145200000
Depreciation & amortization: 143700000
Net tangible assets: 1743100000
Owner earnings: 902600000
Return on net tangible assets (%): 51.78130916183811
Capex to operating income (%): 24.50344827586207
Buffett classification: The Great
Stock price: 149.01
P/E ratio: 8.793121959746903
Shares outstanding: 65749255
Book value: 4755600000
P/B ratio: 2.0601599141117837
Market cap (USD): 9797296487.55
Debt to equity: 1.626860963916225
Current ratio: 1.0038530196716096
Quick ratio: 0.24507326039696709
Effective tax rate (%): 24.46613788895668
Interest coverage ratio: 6.3624396665204035
COGS to revenue (%): 83.35063800883023
SG&A to revenue (%): 11.494509404363367
Free cash flow (dilution-adjusted): 731100000
Buyback yield (%): 3.661214095703046
Retained earnings: 4990300000
Inventory turnover: 6.0024457850970165
Receivables turnover: 27.737753454153957
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.480306782775425
FCF margin (%): 2.3647566833244387
Revenue growth (%): 11.151257603865568
Rule of 40 score: 13.516014287190007
Financial ratios for PAG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 153.59
Shares outstanding: 65749255
Market cap (USD): 10098428075.45
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PAG — annual report dated 2024-12-31
Total revenue: 31864800000
Gross profit: 5217100000
Operating income: 1370100000
Net income: 973400000
Capital expenditures: 351600000
Operating cash flow: 1230600000
Depreciation & amortization: 161300000
Net tangible assets: 1884000000
Owner earnings: 783100000
Return on net tangible assets (%): 41.56581740976645
Capex to operating income (%): 25.662360411648784
Buffett classification: The Good
Stock price: 145.22
P/E ratio: 9.809026927367988
Shares outstanding: 65749255
Book value: 5418500000
P/B ratio: 1.7621309977115436
Market cap (USD): 9548106811.1
Debt to equity: 1.5575159176893973
Current ratio: 0.9188067957329119
Quick ratio: 0.20296021639364192
Effective tax rate (%): 24.53678579734863
Interest coverage ratio: 4.877536489854041
COGS to revenue (%): 83.62738821520927
SG&A to revenue (%): 11.566681730310561
Free cash flow (dilution-adjusted): 823400000
Buyback yield (%): 0.6147815599607583
Retained earnings: 5756400000
Inventory turnover: 5.656845054875071
Receivables turnover: 30.721943694562285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.998681251956775
FCF margin (%): 2.584042579900078
Revenue growth (%): 3.0672941633108532
Rule of 40 score: 5.651336743210932
Financial ratios for PAG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 145.22
Shares outstanding: 65749255
Market cap (USD): 9548106811.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PAG — quarterly report dated 2025-03-31
Total revenue: 7953800000
Gross profit: 1321400000
Operating income: 329400000
Net income: 258400000
Capital expenditures: 80700000
Operating cash flow: 291000000
Depreciation & amortization: 40600000
Net tangible assets: 2005100000
Owner earnings: 218300000
Return on net tangible assets (%): 10.887237544262133
Capex to operating income (%): 24.499089253187613
Buffett classification: The Great
Stock price: 138.19
P/E ratio: 8.790527813902864
Shares outstanding: 65749255
Book value: 5412700000
P/B ratio: 1.678624263020304
Market cap (USD): 9085889548.45
Debt to equity: 1.496314223954773
Current ratio: 0.9032392832097402
Quick ratio: 0.23176317870518195
Effective tax rate (%): 26.276747503566334
Interest coverage ratio: 5.1069767441860465
COGS to revenue (%): 83.38655736880484
SG&A to revenue (%): 11.961578113606075
Free cash flow (dilution-adjusted): 198300000
Buyback yield (%): 0.43914247237142234
Retained earnings: 5704300000
Inventory turnover: 1.4737684154389707
Receivables turnover: 6.619340878828229
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2200043011593578
FCF margin (%): 2.493147929291659
Rule of 40 score: 2.493147929291659
Financial ratios for PAG — quarterly report dated 2025-06-30
Total revenue: 7662300000
Gross profit: 1296600000
Operating income: 348200000
Net income: 250900000
Capital expenditures: 46200000
Operating cash flow: 181400000
Depreciation & amortization: 42100000
Net tangible assets: 2153200000
Owner earnings: 246800000
Return on net tangible assets (%): 11.462010031580903
Capex to operating income (%): 13.268236645605974
Buffett classification: The Great
Stock price: 166.19
P/E ratio: 21.45468032289417
Shares outstanding: 65749255
Book value: 5631400000
P/B ratio: 1.9403467500887879
Market cap (USD): 10926868688.45
Debt to equity: 1.4941044855630927
Current ratio: 0.8996224580270572
Quick ratio: 0.2060892943969339
Effective tax rate (%): 25.526862570495695
Interest coverage ratio: 5.36517719568567
COGS to revenue (%): 83.08732364955692
SG&A to revenue (%): 11.828041188677028
Free cash flow (dilution-adjusted): 109800000
Buyback yield (%): 0.6525199673660035
Retained earnings: 5786100000
Inventory turnover: 1.3127680633454306
Receivables turnover: 7.345700316364682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.347819398507807
FCF margin (%): 1.4329900943580909
Revenue growth (%): -3.6649148834519347
Rule of 40 score: -2.231924789093844
Financial ratios for PAG — quarterly report dated 2025-09-30
Total revenue: 7695300000
Gross profit: 1249100000
Operating income: 298700000
Net income: 213500000
Capital expenditures: 73800000
Operating cash flow: 379500000
Depreciation & amortization: 42900000
Net tangible assets: 2239700000
Owner earnings: 182600000
Return on net tangible assets (%): 8.152877617538064
Capex to operating income (%): 24.70706394375628
Buffett classification: The Great
Stock price: 169.44
P/E ratio: 15.413051697841727
Shares outstanding: 65749255
Book value: 5725300000
P/B ratio: 1.9458462905349938
Market cap (USD): 11140553767.2
Debt to equity: 1.3849405271339492
Current ratio: 0.9693818322530715
Quick ratio: 0.21076392247912032
Effective tax rate (%): 26.933607118412045
Interest coverage ratio: 4.602465331278891
COGS to revenue (%): 83.76801424245969
SG&A to revenue (%): 11.79291255701532
Free cash flow (dilution-adjusted): 293000000
Buyback yield (%): 0.07001447291574273
Retained earnings: 5910900000
Inventory turnover: 1.3700452700261418
Receivables turnover: 7.747206282090003
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.736199915724676
FCF margin (%): 3.8075188751575637
Revenue growth (%): 0.4306800830037978
Rule of 40 score: 4.2381989581613615
Financial ratios for PAG — annual report dated 2025-12-31
Total revenue: 31808500000
Gross profit: 5217000000
Operating income: 1280700000
Net income: 937900000
Capital expenditures: 297100000
Operating cash flow: 975100000
Depreciation & amortization: 172300000
Net tangible assets: 1962500000
Owner earnings: 813100000
Return on net tangible assets (%): 41.43184713375796
Capex to operating income (%): 23.19825095650816
Buffett classification: The Great
Stock price: 155.57
P/E ratio: 10.905865870935067
Shares outstanding: 65749255
Book value: 5580900000
P/B ratio: 1.832788905078034
Market cap (USD): 10228611600.35
Debt to equity: 1.5627049400634305
Current ratio: 0.9862241404022869
Quick ratio: 0.2194422767594082
Effective tax rate (%): 25.781435467278623
Interest coverage ratio: 4.884439359267734
COGS to revenue (%): 83.59872361161325
SG&A to revenue (%): 11.83331499441973
Free cash flow (dilution-adjusted): 620300000
Buyback yield (%): 1.5554408185227793
Retained earnings: 5750100000
Inventory turnover: 5.522981701871353
Receivables turnover: 29.71923759693544
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.315003622356121
FCF margin (%): 1.9501076756212963
Revenue growth (%): -0.17668398985714645
Rule of 40 score: 1.7734236857641499
Financial ratios for PAG — quarterly report dated 2025-12-31
Total revenue: 8846400000
Gross profit: 1402300000
Operating income: 318300000
Net income: 228500000
Capital expenditures: 96400000
Operating cash flow: 123200000
Depreciation & amortization: 47400000
Net tangible assets: 1962500000
Owner earnings: 179500000
Return on net tangible assets (%): 9.146496815286625
Capex to operating income (%): 30.285893810870245
Buffett classification: The Good
Stock price: 155.57
P/E ratio: 10.752245979554294
Shares outstanding: 65749255
Book value: 5580900000
P/B ratio: 1.832788905078034
Market cap (USD): 10228611600.35
Debt to equity: 1.5627049400634305
Current ratio: 0.9862241404022869
Quick ratio: 0.2194422767594082
Effective tax rate (%): 23.19327731092437
Interest coverage ratio: 4.6535087719298245
COGS to revenue (%): 84.14835413275456
SG&A to revenue (%): 11.71776089708808
Free cash flow (dilution-adjusted): 19200000
Buyback yield (%): 0.3920375664535729
Retained earnings: 5750100000
Inventory turnover: 1.5461191766880595
Receivables turnover: 8.26534616462674
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.812185252593077
FCF margin (%): 0.2170374389582203
Revenue growth (%): 14.958481150832325
Rule of 40 score: 15.175518589790546
Financial ratios for PAUSHAKLTD.NS — quarterly report dated 2025-12-31
Total revenue: 5436114.514871338
Gross profit: 4326612.454049237
Operating income: 720730.756377409
Net income: 687312.019605659
Capital expenditures: 0
Depreciation & amortization: 551409.1567338755
Owner earnings: 1238721.1763395346
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.624707586053248
P/E ratio: 38.99257236034323
Shares outstanding: 24656912
Market cap (USD): 163344831.97504735
Effective tax rate (%): 16.846361185983827
Interest coverage ratio: 647
COGS to revenue (%): 20.40983606557377
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -17.96812564323108
Rule of 40 score: -17.96812564323108
Financial ratios for POWERINDIA.NS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 33.87048233239285
Shares outstanding: 44572363
Market cap (USD): 1509687433.5045006
Buyback yield (%): 0
Retained earnings: 81530296.92328362
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for POWERINDIA.NS — annual report dated 2023-03-31
Total revenue: 527953714.9817296
Gross profit: 149347137.63702804
Operating income: 25813641.900121804
Net income: 11437271.61997564
Capital expenditures: 1449451.8879415349
Operating cash flow: 654080.389768575
Depreciation & amortization: 9763702.801461633
Net tangible assets: 144023142.50913522
Owner earnings: 19751522.533495735
Return on net tangible assets (%): 13.714131069069627
Capex to operating income (%): 5.615061576935781
Buffett classification: The Great
Stock price: 40.66577344701584
P/E ratio: 158.47919643618744
Shares outstanding: 44572363
Book value: 148028014.61632156
P/B ratio: 12.244774210166954
Market cap (USD): 1812569615.7561512
Debt to equity: 0.27508207782376515
Current ratio: 1.1572796660613778
Quick ratio: 0.849147446861414
Effective tax rate (%): 28.22198440605412
Interest coverage ratio: 5.286355699675729
COGS to revenue (%): 71.71207751759141
SG&A to revenue (%): 5.560502941515746
Free cash flow (dilution-adjusted): -808769.7929354446
Buyback yield (%): 0
Retained earnings: 84013398.29476249
Inventory turnover: 3.800415698740677
Receivables turnover: 2.8371417163578285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.7648896869784
FCF margin (%): -0.15318952589687393
Rule of 40 score: -0.15318952589687393
Financial ratios for POWERINDIA.NS — annual report dated 2024-03-31
Total revenue: 611109245.7129152
Gross profit: 167319822.52068594
Operating income: 32973977.695167284
Net income: 19640244.63364912
Capital expenditures: 10665547.42774913
Operating cash flow: 30256625.49466363
Depreciation & amortization: 10793860.175080946
Net tangible assets: 159188152.05660152
Owner earnings: 19768557.380980935
Return on net tangible assets (%): 12.418359736943207
Capex to operating income (%): 32.34534676510165
Buffett classification: The Good
Stock price: 83.58001439539348
P/E ratio: 189.6798543330842
Shares outstanding: 44572363
Book value: 163073510.01319098
P/B ratio: 22.844659079671246
Market cap (USD): 3725358741.1767035
Debt to equity: 0.15713266709317808
Current ratio: 1.1633471582881363
Quick ratio: 0.8935508864682558
Effective tax rate (%): 26.12539467749211
Interest coverage ratio: 5.906981740064447
COGS to revenue (%): 72.6203091027543
SG&A to revenue (%): 3.795299879906751
Free cash flow (dilution-adjusted): 19540712.315625373
Buyback yield (%): 0
Retained earnings: 100049166.56673463
Inventory turnover: 4.1678041309097456
Receivables turnover: 3.3488903930446665
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.415768736495746
FCF margin (%): 3.197580866712192
Revenue growth (%): 15.750534255462762
Rule of 40 score: 18.948115122174954
Financial ratios for POWERINDIA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 163591734.3526039
Buffett classification: The Gruesome
Stock price: 173.68705207835643
Shares outstanding: 44572363
Book value: 167535833.73148596
P/B ratio: 46.20887461033643
Market cap (USD): 7741642333.636407
Debt to equity: 0.24743870355979203
Current ratio: 1.1705008769993843
Quick ratio: 0.8880431878637225
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for POWERINDIA.NS — quarterly report dated 2024-12-31
Total revenue: 184483039.9813498
Gross profit: 69108287.67921668
Operating income: 16775848.00093251
Net income: 16013521.389439328
Capital expenditures: 0
Depreciation & amortization: 2679799.510432451
Owner earnings: 18693320.899871778
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 167.9452150600303
P/E ratio: 116.86553675048407
Shares outstanding: 44572363
Market cap (USD): 7485715089.768738
Effective tax rate (%): 25.36129522981636
Interest coverage ratio: 12.023391812865498
COGS to revenue (%): 62.539489979022925
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for POWERINDIA.NS — quarterly report dated 2025-03-31
Total revenue: 215156651.8587795
Gross profit: 76856441.43090951
Operating income: 25074818.798223052
Net income: 21497545.008183304
Capital expenditures: 0
Depreciation & amortization: 2744914.6598082767
Net tangible assets: 488804068.2721533
Owner earnings: 24242459.667991582
Return on net tangible assets (%): 4.959545396928656
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 147.62492706266775
P/E ratio: 76.52027050508553
Shares outstanding: 44572363
Book value: 492647884.03086275
P/B ratio: 13.356378967972054
Market cap (USD): 6579991836.885751
Debt to equity: 0.020989010728243922
Current ratio: 1.7554131750115196
Quick ratio: 1.5410604751969952
Effective tax rate (%): 25.451007418818666
Interest coverage ratio: 35.80801335559266
COGS to revenue (%): 64.27884484772747
Buyback yield (%): 0
Retained earnings: 139925181.20177692
Inventory turnover: 1.277959620183427
Receivables turnover: 0.8724248428597161
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.994306923200511
Revenue growth (%): 16.62679229512405
Rule of 40 score: 16.62679229512405
Financial ratios for POWERINDIA.NS — annual report dated 2025-03-31
Total revenue: 727623334.1126958
Gross profit: 264016834.22960016
Operating income: 58973579.61187748
Net income: 44888940.846387655
Capital expenditures: 14880757.540332008
Operating cash flow: 174628244.09632918
Depreciation & amortization: 10679214.402618658
Net tangible assets: 488804068.2721533
Owner earnings: 40687397.70867431
Return on net tangible assets (%): 8.323866422081542
Capex to operating income (%): 25.232922332791503
Buffett classification: The Good
Stock price: 147.62492706266775
P/E ratio: 146.58380689806947
Shares outstanding: 44572363
Book value: 492647884.03086275
P/B ratio: 13.356378967972054
Market cap (USD): 6579991836.885751
Debt to equity: 0.020989010728243922
Current ratio: 1.7554131750115196
Quick ratio: 1.5410604751969952
Effective tax rate (%): 25.641472530451793
Interest coverage ratio: 11.15075154730327
COGS to revenue (%): 63.71517764042615
SG&A to revenue (%): 4.522428178255777
Free cash flow (dilution-adjusted): 159537058.68599483
Buyback yield (%): 0
Retained earnings: 139925181.20177692
Inventory turnover: 4.283944215791123
Receivables turnover: 2.9503929692166215
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.74613301542137
FCF margin (%): 21.92577549489162
Revenue growth (%): 19.06599993653446
Rule of 40 score: 40.99177543142608
Financial ratios for POWERINDIA.NS — quarterly report dated 2025-06-30
Total revenue: 167253685.93494034
Gross profit: 71029721.50713785
Operating income: 16294172.712380063
Net income: 15399017.084015915
Capital expenditures: 0
Depreciation & amortization: 2926515.3288088
Owner earnings: 18325532.412824716
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 234.04165691551606
P/E ratio: 197.1607112050768
Shares outstanding: 44572363
Market cap (USD): 10431789689.159842
Effective tax rate (%): 25.599276345545004
Interest coverage ratio: 35.25316455696203
COGS to revenue (%): 57.531745198866616
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -22.26422725488441
Rule of 40 score: -22.26422725488441
Financial ratios for POWERINDIA.NS — quarterly report dated 2025-12-31
Total revenue: 225165422.74702018
Gross profit: 84835691.21087223
Operating income: 35507407.819984406
Net income: 29121087.222902976
Capital expenditures: 0
Depreciation & amortization: 2958672.162192269
Owner earnings: 32079759.385095246
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 203.96569009691436
P/E ratio: 110.82656385936292
Shares outstanding: 44572363
Market cap (USD): 9091232778.545172
Effective tax rate (%): 24.831790212203117
Interest coverage ratio: 125.98814229249012
COGS to revenue (%): 62.322948978632674
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 34.625088522477654
Rule of 40 score: 34.625088522477654
Financial ratios for QLYS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 137.22
Shares outstanding: 35217007
Market cap (USD): 4832477700.54
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QLYS — annual report dated 2022-12-31
Total revenue: 489723000
Gross profit: 386935000
Operating income: 130547000
Net income: 107992000
Capital expenditures: 15361000
Operating cash flow: 198854000
Depreciation & amortization: 34622000
Net tangible assets: 268881000
Owner earnings: 127253000
Return on net tangible assets (%): 47.32688438379803
Capex to operating income (%): 11.766643431101443
Buffett classification: The Great
Stock price: 112.23
P/E ratio: 36.599050814967775
Shares outstanding: 35217007
Book value: 289129000
P/B ratio: 13.670038963957266
Market cap (USD): 3952404695.61
Debt to equity: 0.14588989689723272
Current ratio: 1.3439924131429803
Quick ratio: 1.3439924131429803
Effective tax rate (%): 19.228122662677634
COGS to revenue (%): 20.98900807191004
R&D to revenue (%): 20.661884371369123
SG&A to revenue (%): 31.6917931157001
Free cash flow (dilution-adjusted): 121465000
Buyback yield (%): 8.029137308547355
Retained earnings: -221447000
Receivables turnover: 4.020879346442793
Capitalized R&D asset: 101186000
ROCI (R&D-adjusted, %): 44.00692834658328
FCF margin (%): 24.80279668302285
Rule of 40 score: 24.80279668302285
Financial ratios for QLYS — annual report dated 2023-12-31
Total revenue: 554458000
Gross profit: 446973000
Operating income: 163069000
Net income: 151595000
Capital expenditures: 8786000
Operating cash flow: 244605000
Depreciation & amortization: 26991000
Net tangible assets: 351012000
Owner earnings: 169800000
Return on net tangible assets (%): 48.37441454992992
Capex to operating income (%): 5.3879032802065385
Buffett classification: The Great
Stock price: 196.28
P/E ratio: 45.59777125868268
Shares outstanding: 35217007
Book value: 368174000
P/B ratio: 18.774802495450523
Market cap (USD): 6912394133.96
Debt to equity: 0.07806634906321468
Current ratio: 1.541587017738587
Quick ratio: 1.541587017738587
Effective tax rate (%): 15.144611561088379
COGS to revenue (%): 19.385598187779777
R&D to revenue (%): 19.924322491514236
SG&A to revenue (%): 31.279555890617505
Free cash flow (dilution-adjusted): 166740000
Buyback yield (%): 2.4709239185432765
Retained earnings: -228080000
Receivables turnover: 3.7917880541080247
Capitalized R&D asset: 178266620
ROCI (R&D-adjusted, %): 33.7371150192496
Rosenberg metric: 0.593342952582373
FCF margin (%): 30.072611451182958
Revenue growth (%): 13.218697100197458
Rule of 40 score: 43.29130855138042
Financial ratios for QLYS — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 3646000
Buffett classification: The Gruesome
Stock price: 128.46
Shares outstanding: 35217007
Market cap (USD): 4523976719.22
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QLYS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 140.22
Shares outstanding: 35217007
Market cap (USD): 4938128721.54
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QLYS — annual report dated 2024-12-31
Total revenue: 607571000
Gross profit: 496089000
Operating income: 187196000
Net income: 173680000
Capital expenditures: 12334000
Operating cash flow: 244094000
Depreciation & amortization: 18513000
Net tangible assets: 462857000
Owner earnings: 179859000
Return on net tangible assets (%): 38.85843791927096
Capex to operating income (%): 6.588816000341888
Buffett classification: The Great
Stock price: 140.22
P/E ratio: 28.43233948376324
Shares outstanding: 35217007
Book value: 477116000
P/B ratio: 10.349954144359023
Market cap (USD): 4938128721.54
Debt to equity: 0.09897173852899505
Current ratio: 1.367191110903616
Quick ratio: 1.367191110903616
Effective tax rate (%): 17.225076493408697
COGS to revenue (%): 18.348802033013424
R&D to revenue (%): 18.409700265483377
SG&A to revenue (%): 32.43094222732816
Free cash flow (dilution-adjusted): 154627000
Buyback yield (%): 2.832550706705327
Retained earnings: -189217000
Receivables turnover: 3.6922960054937377
Capitalized R&D asset: 219259620
ROCI (R&D-adjusted, %): 25.014348166337612
Rosenberg metric: 0.44460134694764286
FCF margin (%): 25.450029708462058
Revenue growth (%): 9.57926479553005
Rule of 40 score: 35.029294503992105
Financial ratios for QLYS — quarterly report dated 2025-03-31
Total revenue: 159899000
Gross profit: 130973000
Operating income: 51755000
Net income: 47534000
Capital expenditures: 2038000
Operating cash flow: 109588000
Depreciation & amortization: 4177000
Net tangible assets: 484416000
Owner earnings: 49673000
Return on net tangible assets (%): 10.254202999075176
Capex to operating income (%): 3.9377837890058927
Buffett classification: The Great
Stock price: 125.93
P/E ratio: 23.324765912346955
Shares outstanding: 35217007
Book value: 498035000
P/B ratio: 8.904751054664834
Market cap (USD): 4434877691.51
Debt to equity: 0.09766984248095013
Current ratio: 1.3933032118288629
Quick ratio: 1.3933032118288629
Effective tax rate (%): 18.476340748109145
COGS to revenue (%): 18.090169419446024
R&D to revenue (%): 18.2327594293898
SG&A to revenue (%): 31.30976428870725
Free cash flow (dilution-adjusted): 88730000
Buyback yield (%): 0.8941171044223055
Retained earnings: -179668000
Receivables turnover: 1.3153591142041574
Capitalized R&D asset: 29154000
ROCI (R&D-adjusted, %): 11.99315360421296
FCF margin (%): 55.491278869786555
Rule of 40 score: 55.491278869786555
Financial ratios for QLYS — quarterly report dated 2025-06-30
Total revenue: 164062000
Gross profit: 135185000
Operating income: 51407000
Net income: 47290000
Capital expenditures: 1327000
Operating cash flow: 33771000
Depreciation & amortization: 3978000
Net tangible assets: 495187000
Owner earnings: 49941000
Return on net tangible assets (%): 10.085280914078924
Capex to operating income (%): 2.581360515104947
Buffett classification: The Great
Stock price: 142.87
P/E ratio: 53.06097391050789
Shares outstanding: 35217007
Book value: 508167000
P/B ratio: 9.901181678641077
Market cap (USD): 5031453790.09
Debt to equity: 0.10891498267301891
Current ratio: 1.3026690498182647
Quick ratio: 1.3026690498182647
Effective tax rate (%): 19.592607076666724
COGS to revenue (%): 17.60127268959296
R&D to revenue (%): 18.437541904889613
SG&A to revenue (%): 32.62729943557923
Free cash flow (dilution-adjusted): 14398000
Buyback yield (%): 0.9916020713191834
Retained earnings: -179669000
Receivables turnover: 1.2750106858364096
Capitalized R&D asset: 49782180
ROCI (R&D-adjusted, %): 9.77987680027286
Rosenberg metric: 0.1444741716402552
FCF margin (%): 8.775950555277882
Revenue growth (%): 2.6035184710348407
Rule of 40 score: 11.379469026312723